Evidence map›Paper›PMID 23040839›Full record

ReviewTrends in cardiovascular medicine2012

Genetic pathways of vascular calcification.

Marion A Hofmann Bowman, Elizabeth M McNally

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Trends in cardiovascular medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05973994 (Shockwave Induced Attenuation of Calcified Plaques Quantified With OCT), which is not on this map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05973994 unknown statusnot on this mapstarted 2022, after this paper: background citation

Shockwave Induced Attenuation of Calcified Plaques Quantified With OCT

Typeobservational_patient_registrySponsorUniversity of Rome Tor VergataRan2022 to 2024Enrolled30ConditionsCoronary Artery CalcificationArmsintravascular lithotripsy with Shockwave coronary system
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. The synergism of cytosolic acidosis and reduced NADJournal of biomedical science · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Vessel wall calcification and vascular event: Are we concerned enough?Journal of family medicine and primary care · 2022
    Article
  12. Article
  13. Review
  14. Review
  15. Role of Glycosylation in Vascular Calcification.International journal of molecular sciences · 2021
    Review
  16. Review
  17. Article
  18. LncRNA H19/Runx2 axis promotes VSMCs transition via MAPK pathway.American journal of translational research · 2020
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Marion A Hofmann BowmanDepartment of Medicine, Section of Cardiology, The University of Chicago, Chicago, IL 60637, USA.
Elizabeth M McNally
University of Chicago · US

Funding

Training and education CoreU54AR052646 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI MCNALLY, ELIZABETH M, SWEENEY, H LEE · 2005 to 2020
$24.1M
SARCOGLYCAN IN MYOPATHY AND MUSCLE MEMBRANE STABILITYR01HL061322 · NHLBI · UNIVERSITY OF CHICAGO · PI MCNALLY, ELIZABETH M · 1999 to 2022
$7.5M
Understanding and Improving Therapies for the Muscular Dystrophies through Noninvasive BiomarkersP50AR052646 · NIAMS · UNIVERSITY OF FLORIDA · PI WALTER, GLENN · 2021 to 2024
$6.2M
Regulation of TGF - (beta) pathways in muscular dystrophy fibrosisP01NS072027 · NINDS · UNIVERSITY OF CHICAGO · PI HEYDEMANN, AHLKE · 2011 to 2015
$6.2M
Pro-inflammatory S100 protein as disease modifier in calcific aortic valve diseasR01HL114821 · NHLBI · UNIVERSITY OF CHICAGO · PI HOFMANN BOWMAN, MARION A · 2012 to 2015
$1.5M
Pro-inflammatory S100A12 in atherosclerosis and acute coronary syndromeK08HL090917 · NHLBI · UNIVERSITY OF CHICAGO · PI HOFMANN BOWMAN, MARION A · 2008 to 2012
$621k
NHLBI NIH HHS HL061322NHLBI NIH HHS HL090917NHLBI NIH HHS K08 HL090917NHLBI NIH HHS R01 HL061322NHLBI NIH HHS R01 HL114821NIAMS NIH HHS AR052646NIAMS NIH HHS P50 AR052646NIAMS NIH HHS U54 AR052646NINDS NIH HHS NS072027NINDS NIH HHS P01 NS072027
6 · The paper itself

Abstract

Vascular calcification is an independent risk factor for cardiovascular disease. Arterial calcification of the aorta and coronary, carotid, and peripheral arteries becomes more prevalent with age. Genome-wide association studies have identified regions of the genome linked to vascular calcification, and these same regions are linked to myocardial infarction risk. The 9p21 region linked to vascular disease and inflammation also associates with vascular calcification. In addition to these common variants, rare genetic defects can serve as primary triggers of accelerated and premature calcification. Infancy-associated calcific disorders are caused by loss-of-function mutations in ENPP1, an enzyme that produces extracellular pyrophosphate. Adult-onset vascular calcification is linked to mutations in NTE5, another enzyme that regulates extracellular phosphate metabolism. Common conditions that secondarily enhance vascular calcification include atherosclerosis, metabolic dysfunction, diabetes, and impaired renal clearance. Oxidative stress and vascular inflammation, along with biophysical properties, converge with these predisposing factors to promote soft tissue mineralization. Vascular calcification is accompanied by an osteogenic profile, and this osteogenic conversion is seen within the vascular smooth muscle as well as the matrix. Here, we review the genetic causes of medial calcification in the smooth muscle layer, focusing on recent discoveries of gene mutations that regulate extracellular matrix phosphate production and the role of S100 proteins as promoters of vascular calcification.

Indexed as

AdultAnimalsHumansInfantMiceReceptor for Advanced Glycation End ProductsReceptors, ImmunologicS100 ProteinsVascular CalcificationReceptor for Advanced Glycation End ProductsReceptors, ImmunologicS100 Proteins

Identifiers

PMID23040839
PMCPMC3466440
OpenAlexW1977186226

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.